Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare®

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

October 6, 2022

Study Completion Date

October 6, 2022

Conditions
Lung CancerNeoplasms, LungNeoplasms, PulmonaryPulmonary CancerPulmonary NeoplasmsCancer of Lung
Interventions
DEVICE

Moovcare® use

Moovcare® performs symptom monitoring by automatically delivering ePRO surveys on common symptoms experienced by lung cancer patients. Results are stored in a secure web-based portal for provider review. Providers will manage ePRO responses through a combination of reports graphically displaying responses over time and e-mail alerts about concerning levels or combinations of symptoms.

Trial Locations (1)

27599

Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Sivan Innovation Ltd.

INDUSTRY

lead

UNC Lineberger Comprehensive Cancer Center

OTHER

NCT05011890 - Remote Monitoring of Lung Cancer Patient-Reported Outcomes Using Moovcare® | Biotech Hunter | Biotech Hunter